EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   1.1.1.B40 | 11beta-hydroxysteroid dehydrogenase (nad+) deficiency |
1327632 |
Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. |
causal interaction
ongoing research
unassigned |
4
1
0 |
| 1.1.1.B40 | Hypertension |
1327632 |
Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. |
causal interaction
ongoing research
unassigned |
4
1
0 |
| 1.1.1.B40 | ACTH Syndrome, Ectopic |
1337504 |
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.B40 | Mineralocorticoid Excess Syndrome, Apparent |
1476186 |
Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone. |
causal interaction
unassigned |
1
0 |
| 1.1.1.B40 | Hypertension |
1879383 |
Defects in cortisol metabolism causing low-renin hypertension. |
causal interaction
ongoing research
unassigned |
4
2
0 |
| 1.1.1.B40 | Eczema |
1970371 |
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.1.B40 | Psoriasis |
1970371 |
Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 1.1.1.B40 | Vaccinia |
2082184 |
Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
| 1.1.1.B40 | Hypertension |
2316675 |
The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.B40 | Hypertension |
2508491 |
Effect of carbenoxolone on glucocorticoid metabolism and Na transport in toad bladder. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
